Dengue vaccines: what we know, what has been done, but what does the future hold?

Dengue, a disease caused by any of the four serotypes of dengue viruses, is the most important arthropod-borne viral disease in the world in terms of both morbidity and mortality. The infection by these viruses induces a plethora of clinical manifestations ranging from asymptomatic infections to sev...

Descripción completa

Detalles Bibliográficos
Autores: Abrão, Emiliana Pereira, Espósito, Danillo Lucas Alves, Lauretti, Flávio, Fonseca, Benedito Antonio Lopes da
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2015
País:Brasil
Institución:Universidade de São Paulo (USP)
Repositorio:Revista de Saúde Pública
Idioma:inglés
OAI Identifier:oai:revistas.usp.br:article/130478
Acceso en línea:https://www.revistas.usp.br/rsp/article/view/130478
Access Level:acceso abierto
Palabra clave:Vacinas contra Dengue
Dengue
prevenção & controle
Pesquisa Científica e Desenvolvimento Tecnológico
Controle de Doenças Transmissíveis
Dengue Vaccines
prevention & control
Scientific Research and Technological Development
Communicable Disease Control
Descripción
Sumario:Dengue, a disease caused by any of the four serotypes of dengue viruses, is the most important arthropod-borne viral disease in the world in terms of both morbidity and mortality. The infection by these viruses induces a plethora of clinical manifestations ranging from asymptomatic infections to severe diseases with involvement of several organs. Severe forms of the disease are more frequent in secondary infections by distinct serotypes and, consequently, a dengue vaccine must be tetravalent. Although several approaches have been used on the vaccine development, no vaccine is available against these viruses, especially because of problems on the development of a tetravalent vaccine. Here, we describe briefly the vaccine candidates available and their ability to elicit a protective immune response. We also discuss the problems and possibilities of any of the vaccines in final development stage reaching the market for human use.